Mold & Mycotoxins

Mold & Mycotoxins: A Nutrition and Natural-Health Reference

1. Definition and Overview

Mycotoxins are toxic metabolic compounds produced by some molds. They are toxic compounds produced by fungi such as Aspergillus, Penicillium, Rhizopus, Fusarium spp., and mushrooms. They are present in the mycelium or in the spores of the fungus. The term "mold" refers to the visible, multicellular fungal growth; mycotoxins are the chemically stable secondary metabolites those molds produce. Many mycotoxins have chemical stability and can survive the rigors encountered throughout the food supply chain.

There are at least 21 different mycotoxin classes, with over 400 individual toxins produced by at least 350 fungi. The most common mycotoxins of concern to humans and livestock include aflatoxins, citrinin, ochratoxins, fumonisins, patulin, zearalenone, nivalenol, deoxynivalenol, and ergot alkaloids. Apart from acute and chronic toxic effects on human health called mycotoxicosis, some mycotoxins are proved or suspected human carcinogens.

The clinical symptoms of mycotoxicosis depend on the intrinsic toxic features of the mycotoxin, the quantity, and length of exposure. The diseases caused by ingesting mycotoxins are referred to as mycotoxicoses. Mycotoxicoses often remain unrecognized by medical professionals, except when large numbers of people are involved.

2. Routes of Exposure

The most common route of exposure to mycotoxins is ingestion, but it may also involve dermal, respiratory, and parenteral routes, the last being associated with drug abuse. Although they occur more frequently in areas with a hot and humid climate, favourable for the growth of moulds, they can also be found in temperate zones. They are produced by various strains of moulds, particularly in tropical countries. Due to significant trade of cereals, humans in temperate countries can also be exposed to mycotoxins.

Almost all of the studies to date focus on disease induced by mycotoxins ingested in contaminated food, but mycotoxins are secondary metabolites of fungal spores and can enter the body through the respiratory tract. In heavily contaminated environments, neurotoxic symptoms related to airborne mycotoxin exposure have been reported.

Dermal contact with mycotoxin-contaminated items can also be a source of exposure which has the potential to occur even after a person has removed themselves from the contaminated environment since many people bring mold and mycotoxin-contaminated items to their new settings. One study showed that aflatoxin B1, OTA, citrinin, T2 toxin, and zearalenone all penetrated human skin in vitro and that ochratoxin had the highest permeability.

Although there is agreement that diet is the main source of mycotoxin exposure, specific health effects and risk assessment from indoor non-agricultural exposure are limited by the paucity of scientific evidence currently available.

3. Major Mycotoxin Classes and Their Characteristics

Aflatoxins

Aflatoxin B1 (AFB1), the most potent and widespread mycotoxin produced by Aspergillus flavus and Aspergillus parasiticus, poses a significant global threat to food safety and human health, with chronic exposure strongly linked to hepatocellular carcinoma (HCC). Aflatoxin, a type of mycotoxin found on corn and other grains, seeds, or nut crops, has been listed by the National Toxicology Program (NTP) as a human carcinogen.

Ochratoxin A (OTA)

Reviews suggest both a direct, DNA adduct-mediated mechanism and an oxidative stress-mediated mechanism as causes of the carcinogenicity of OTA. OTA is primarily nephrotoxic and has been associated with urinary tract cancers in epidemiological studies.

Trichothecenes (including Deoxynivalenol and T-2 Toxin)

Alimentary toxic aleukia (ATA) in humans, which is linked to exposure to trichothecenes, was first reported in eastern Siberia in 1913 and appeared again in 1932 in many western Siberia districts. ATA presents with fever, agranulocytosis, necrotic angina, gum bleeding, mouth bleeding, nose bleeding, diarrhea, vomiting, and abdominal pain, and is associated with a high rate of mortality. T-2 toxin has collected impressive consideration because of its powerful neurotoxicity, as it can cross the blood–brain barrier and accumulate in the CNS. In vitro and animal model studies show that T-2 toxin induces reactive oxygen species (ROS) and oxidative stress causing neurotoxicity, as well as mitochondrial dysfunction by affecting crucial pathways including p53, Akt/mTOR, MAPK, NF-κB, and PKA/CREB.

Zearalenone (ZEA)

Exposure to the Fusarium mycotoxin zearalenone (ZEA) leads to precocious sexual development, infertility, the development of malformations, and the development of breast cancer.

Fumonisins

Fumonisins are produced predominantly by Fusarium verticillioides and Fusarium proliferatum and are major contaminants of corn and corn-based products. They are associated with esophageal cancer and neural tube defects in epidemiological research.

Ergot Alkaloids

Produced by Claviceps purpurea on rye and other cereals, ergot alkaloids have a documented history of causing ergotism, characterized by vasoconstrictive and hallucinogenic effects.

Alternaria Toxins

Species of Alternaria are black molds with worldwide distribution, and one-fourth of more than 120 secondary metabolites known thus far are mycotoxins. Fungal species belonging to the Alternaria genus have been shown to have extensive distribution in plants as well as in decaying fruits and vegetables, and as their growth occurs at low temperatures, they affect refrigerated products as well. Alternaria toxin exposure was associated with esophageal cancer in South Africa and in the Shanxi province of China.

4. Body Systems Involved

Hepatic System

Scientific literature revealed a linkage between ingesting mycotoxin-contaminated food and illness, especially hepatic, gastrointestinal, and carcinogenic diseases. Aflatoxin B1 undergoes bioactivation in the liver via cytochrome P450 enzymes to form a reactive epoxide that binds to DNA, driving hepatocellular carcinoma risk. There is evidence to suggest that exposure to the Aspergillus mycotoxin aflatoxin during pregnancy can impair intrauterine fetal growth, promote neonatal jaundice, and cause perinatal death and preterm birth.

Renal System

Ochratoxin A is a well-characterized nephrotoxin. OTA was shown to increase the formation of oxidative products of lipids, with increased production of malondialdehyde (MDA), a product of the interaction of polyunsaturated lipids and free radicals. OTA-associated nephropathy has been documented across multiple human studies, particularly in populations with chronic low-level dietary exposure.

Immune System

Associated health concerns arising from mycotoxin exposures include DNA damage, kidney damage, DNA/RNA mutations, growth impairment in children, gene modifications, and immune impairment. Most mycotoxins are cytotoxic and exert their effects by interfering with vital cellular processes such as protein, RNA, and DNA synthesis. As a result, mycotoxins may be damaging to the skin, the lungs, the gut, and the like. The combined outcome may increase the susceptibility of the exposed individual to infectious diseases and, possibly, to cancer. Long-term exposure to inhaled mycotoxins may promote inflammation and immune system changes.

Endocrine and Reproductive System

Research presents results of epidemiological studies, including clinical cases, on the relationship between human exposure to mycotoxins, especially zearalenone and aflatoxin, and the occurrence of reproductive disorders. The analysed data indicate that exposure to these mycotoxins is widespread and correlates strongly with precocious puberty, reduced fertility, and increased cancer incidence in women and men worldwide.

Neurological System

Extended exposure to mold has been linked to short-term memory loss, lightheadedness, dizziness, blurred vision, ringing in the ears, and loss of cognitive functions, also known as "brain fog." Studies have associated prolonged mold exposure with increased levels of depression, anxiety, and stress in both children and adults.

Gastrointestinal System and Gut Microbiome

Exposure to mycotoxins can disrupt gut health, particularly damaging the intestinal epithelium in humans and animals. The fundamental molecular mechanisms include the induction of inflammatory reaction and immune dysfunction, the breakdown of the intestinal barrier, the triggering of oxidative stress, and the intestinal microbiota imbalance. Mycotoxins have been demonstrated to modulate gut microbiota composition, and such alteration can be observed down to the species level. Most of the reported effects of mycotoxins are negative in terms of intestinal health, where beneficial bacteria are eliminated accompanied by an increase of gut pathogens.

Findings revealed that the gut microbiota is capable of eliminating mycotoxin from the host naturally, provided that the host is healthy with a balanced gut microbiota. Recent insights have generated an entirely new perspective where a bi-directional relationship exists between mycotoxins and gut microbiota, thus suggesting that our gut microbiota might be involved in the development of mycotoxicosis.

Respiratory System

Illness resulting from exposure to water-damaged buildings can be caused by infection, toxicity, allergy, and inflammatory responses triggered by exposure to one or more agents present in water-damaged buildings and are often mediated by oxidative stress. Types of disorders seen resulting from water-damaged environments, mold, mycotoxins, and bacteria include infections and mycoses, chronic and fungal rhinosinusitis, IgE-mediated sensitivity and asthma, other hypersensitivity reactions, pulmonary inflammatory disease, and immune suppression. Studies have shown that mold exposure can increase a person's risk of developing asthma or worsen its symptoms — especially for young children.

5. Contributing and Associated Factors

Environmental and Building Conditions

Illness results from a combination of factors present in water-damaged indoor environments including mold spores and hyphal fragments, mycotoxins, bacteria, bacterial endotoxins, and cell wall components as well as other factors. It has been estimated that up to 50% of illness results from exposure to indoor air pollution, with exposure to water-damaged indoor environments likely being a significant contributor to this.

Mycotoxin production is favored when the relative humidity is between 88% and 95%. Periods of high humidity and warming temperatures at night in the spring of the year are very conducive to mold infection of plants and subsequent mold growth and mycotoxin production. Temperature, water activity, pH, oxygen, and substrate composition affect the production of mycotoxin.

The best way to control mold growth indoors is to control moisture. Individuals can act to prevent or eliminate mold in their homes by controlling humidity with HVAC systems or dehumidifiers, using fans and open windows to ventilate and dry indoor spaces, and fixing sources of water problems such as leaking roofs, wet basements, and dripping pipes or faucets.

Agricultural and Dietary Sources

The production of some mycotoxins occurs mainly in the field, while for others, it can happen both in the field and in the postharvest period. High-risk foods include corn, wheat, peanuts, tree nuts (pistachios, Brazil nuts), dried fruits, coffee, spices, and fermented grain products. Mycotoxins produced by fungi (mould) species are unavoidable and are considered more toxic than many pesticides.

Individual Susceptibility Factors

The symptoms of a mycotoxicosis depend on the type of mycotoxin, the concentration and length of exposure, as well as the age, health, and sex of the exposed individual. The synergistic effects associated with several other factors such as genetics, diet, and interactions with other toxins have been poorly studied. It is possible that vitamin deficiency, caloric deprivation, alcohol abuse, and infectious disease status can all have compounded effects with mycotoxins.

Individual responses to exposure vary based on genetic makeup, duration and severity of exposure, and underlying health. Genetic polymorphisms in detoxification enzymes — including glutathione S-transferase (GST) variants — have been identified as factors modulating individual susceptibility, though the extent of this effect in diverse populations requires further study.

Oxidative Stress as a Central Mechanism

Evidence for the role of oxidative stress in the pathophysiology of mycotoxin-related illness is increasing. The glutathione antioxidant and detoxification systems play a major role in the antioxidant function of cells. Exposure to mycotoxins in humans requires the production of glutathione on an "as needed" basis. Research suggests that mycotoxins can decrease the formation of glutathione due to decreased gene expression of the enzymes needed to form glutathione. Mycotoxin-related compromise of glutathione production can result in an excess of oxidative stress that leads to tissue damage and systemic illness.

6. Nutrients, Herbs, and Natural Ingredients

The literature on natural interventions in the context of mycotoxin exposure spans two broad categories: (1) agents that may reduce intestinal absorption of mycotoxins ("binders"), and (2) agents that may mitigate the downstream oxidative, inflammatory, and organ-toxic effects of mycotoxins that have already been absorbed. These categories are addressed separately below. For each ingredient, traditional use and scientific evidence are clearly distinguished.

6.1 Glutathione and Glutathione Precursors

Scientific Evidence

Glutathione is a tripeptide (cysteine, glycine, and glutamic acid) found in relatively high concentrations in many bodily tissues. It plays a pivotal role in reducing oxidative stress, maintaining redox balance, enhancing metabolic detoxification, and regulating the immune system. Research suggests that mycotoxins can decrease the formation of glutathione due to decreased gene expression of the enzymes needed to form glutathione. Mycotoxin-related compromise of glutathione production can result in an excess of oxidative stress that leads to tissue damage and systemic illness.

N-acetylcysteine (NAC) is a cysteine-donating precursor to glutathione. It was shown that the toxicity of ochratoxin A (OTA) could be decreased by maintaining glutathione production with N-acetylcysteine (NAC), which decreased reactive oxygen species (ROS) and 8-oxoguanine formation. These findings suggested that cellular glutathione (GSH) levels play a significant role in limiting the toxicity of the mycotoxin OTA. Certain antioxidants, including N-acetylcysteine (NAC), contribute towards protective effects via activation of Nrf2/HO-1 and autophagy against T-2 toxin–induced injury. These findings are derived primarily from in vitro and animal model data; controlled human clinical trials specifically in mycotoxin-exposed populations are lacking, making the clinical translation of these results preliminary.

Optimizing glutathione levels has been proposed as a strategy for health promotion and disease prevention, although clear, causal relationships between glutathione status and disease risk or treatment remain to be clarified.

6.2 Milk Thistle (Silybum marianum) / Silymarin

Traditional Use

Milk thistle (Silybum marianum), is the most commonly studied herb associated with the treatment of liver diseases. Its use in European herbal medicine for liver and gallbladder conditions dates back to the first century CE, documented in writings by Pliny the Elder and Dioscorides. Silymarin — the standardized flavonolignan complex extracted from milk thistle seeds — has been used as a hepatoprotective remedy throughout Central European folk medicine.

Scientific Evidence

The hepatoprotective effects of active substances in silymarin, with silybin being the main compound, have been demonstrated in many studies. Besides its well-known hepatoprotective properties, silymarin has also been shown to have antioxidant, antifibrotic, anti-inflammatory, choleretic, immune-stimulating, regenerative, cytoprotective, cardioprotective, neuroprotective, and anti-carcinogenic properties.

The majority of evidence relating silymarin to mycotoxin protection comes from animal studies. Silymarin, as a complex of active ingredients derived from milk thistle, was found to be hepato- and nephroprotective against ochratoxin A intoxication in broiler chickens and laying hens. The protective effects of a silymarin product were observed on the liver of broilers fed a diet contaminated with aflatoxin and fumonisin. The use of milk thistle as a whole plant, seed, and its standardized silymarin extract in mycotoxicosis cases produced positive effects on the maintenance of animals' performance, restoring liver functionality due to its known hepatoprotective and antioxidant effects, and reducing organ lesions caused by intoxication. These findings are from poultry and other animal species; controlled human clinical trials in mycotoxin-exposed populations have not been conducted, limiting the direct clinical applicability to humans.

A notable quality concern: milk thistle can be affected by toxigenic micro-fungi and contaminated by mycotoxins with adverse effects. The beneficial effect of silymarin can thus be reduced or totally antagonized by mycotoxins. Milk thistle has proven to be affected by micro-fungi of the Fusarium and Alternaria genera; alternariol-methyl-ether (AME), alternariol (AOH), beauvericin (BEA), deoxynivalenol (DON), enniatin variants, HT-2 toxin, T-2 toxin, tentoxin, and zearalenone (ZEA) seem to be most significant in milk thistle–based dietary supplements.

6.3 Curcumin

Traditional Use

Curcumin is the primary polyphenolic constituent of turmeric (Curcuma longa), used for millennia in Ayurvedic and Traditional Chinese Medicine as an anti-inflammatory, digestive, and hepatoprotective agent. Classical texts including the Charaka Samhita reference turmeric preparations for jaundice and liver ailments.

Scientific Evidence

Curcumin (polyphenolic antioxidant purified from turmeric) was evaluated for possible protection against liver injury induced by aflatoxin B1 in rats. Aflatoxin B1 is a potent hepatotoxic and hepatocarcinogenic mycotoxin. Lipid peroxidation and oxidative DNA damage are the principal manifestations of aflatoxin B1-induced toxicity that could be counteracted by antioxidants. In a study in aflatoxin B1-exposed rats, curcumin showed significant hepatoprotective activity by lowering the levels of serum marker enzymes and lipid peroxidation and by elevating the levels of reduced glutathione, superoxide dismutase, catalase, and glutathione peroxidase. These findings are animal-based. Controlled human studies specifically examining curcumin's role in mycotoxin-associated liver protection have not been reported in the peer-reviewed literature at this time, and evidence must therefore be characterized as preliminary and preclinical.

6.4 Resveratrol

Traditional Use

Resveratrol is a stilbene polyphenol found in grape skins, red wine, and Japanese knotweed (Polygonum cuspidatum). Its use in traditional medicine is linked to red wine consumption in Mediterranean traditions and to Japanese herbal medicine, where knotweed extracts have been used for cardiovascular and inflammatory conditions.

Scientific Evidence

The number of sister chromatid exchanges and micronuclei was reduced in the presence of resveratrol, resulting in decreased genotoxicity of aflatoxin B1. In contrast, a study in aflatoxin B1-exposed rats showed that resveratrol failed to protect against aflatoxin B1-induced liver injury. Cell-line research showed that CYP3A catalytic activity was enhanced by AFB1 alone, while it was significantly reduced by resveratrol. Likewise, resveratrol in combination with AFB1 was shown to reverse the mycotoxin-dependent increase in CYP3A enzymatic activity. Evidence is mixed, derived entirely from in vitro and animal studies, and no human trials specifically addressing resveratrol and mycotoxin exposure have been identified in the literature.

6.5 Probiotics and Lactic Acid Bacteria

Traditional Use

Fermented foods containing lactic acid bacteria — including yogurt, kefir, sauerkraut, and kimchi — have been integral to traditional diets across Europe, the Middle East, and Asia for thousands of years, valued for digestive and preservative properties.

Scientific Evidence

A review synthesized in vivo and clinical evidence on the ability of probiotic lactic acid bacteria — including Lactobacillus casei Shirota, Lactobacillus rhamnosus GG, Lactobacillus rhamnosus LC705, Lactococcus lactis, and selected Bifidobacterium species — to reduce AFB1 absorption and toxicity. Mechanistic insights include cell wall adsorption, gut microbiota modulation, intestinal barrier protection, and antioxidant enhancement.

One human randomized controlled trial found notable results: an RCT examining the effects of Lactobacillus rhamnosus LC705 and Propionibacterium freudenreichii subsp. shermanii strains on liver-cancer risk mediated by aflatoxin exposure found that a five-week intervention led to a statistically significant reduction in aflatoxin exposure in the intervention group and a decreased risk of liver cancer.

A prospective RCT also examined fermented milk containing Lactobacillus casei: a study recruited 71 healthy university employees with urinary aflatoxin M1 levels above 0.005 ng/mL, exploring whether fermented milk containing Lactobacillus casei probiotics could prevent AFB1 absorption in the GI tract. The concentrations of AFB1-lys in blood serum were reduced from 6.24 pg/mg to 5.48 pg/mg (p = 0.035) during the 4-week intervention period. A significant difference of 13.7% was observed between the placebo drink and milk with Lactobacillus casei.

Clinical trials have shown reductions in AFB1 biomarkers following probiotic supplementation, supporting their translational potential for human health. However, clinical evidence remains limited by small sample sizes, short intervention periods, and variability in endpoints.

Saccharomyces boulardii has demonstrated mycotoxin binding effects as well as the ability to reverse mycotoxin-induced injury by attenuating the p38 MAPK signaling pathway to modulate expression of inflammatory cytokines and apoptotic genes. Evidence for S. boulardii in this context is largely derived from in vitro and animal models.

6.6 Activated Charcoal

Traditional Use

Charcoal has been used medicinally since ancient Egypt and Greece as a detoxifying and wound-care agent. Its internal use for poisoning and gastrointestinal complaints is documented in 19th-century pharmacopeias. Historically, activated charcoal has been used in the medical field for treating poisoning and drug overdoses.

Scientific Evidence

A review of sources shows that mycotoxin binders, such as activated charcoal, clay, and yeast cell walls, have the ability to adsorb mycotoxins in the digestive system and prevent them from being absorbed into the bloodstream. In vitro, activated charcoal demonstrates broad-spectrum binding: the deoxynivalenol (DON) sequestering rate of activated charcoal (99.1%) was greater than that of other products tested. Activated charcoal effectively sequestered deoxynivalenol, while a bentonite product, an aluminosilicate product, and activated charcoal all effectively sequestered zearalenone.

A critical limitation is that in vitro binding efficiency does not reliably predict in vivo outcomes: in vitro aflatoxin binding experiments may not give an accurate prediction of in vivo animal protection. Furthermore, although activated charcoal is odorless, tasteless, and non-toxic, it will absorb nutrients, vitamins, and minerals, making its unguided use potentially problematic. Due to possible concurrent adsorption of essential nutrients, activated charcoal should be taken at least two hours after ingestion of food, medication, or supplements. Human clinical trials for mycotoxin-specific binding remain limited; overall evidence is preliminary and largely preclinical.

6.7 Bentonite Clay and Aluminosilicates

Traditional Use

Clay ingestion — a practice known as geophagy — has been documented across numerous cultures on multiple continents and is particularly prevalent in sub-Saharan Africa, parts of Central America, and among some Indigenous North American groups. It has been proposed that this practice may represent an instinctive or culturally transmitted response to toxic food contaminants, including mycotoxins.

Scientific Evidence

Bentonite (primarily montmorillonite) demonstrates high affinity for aflatoxins in laboratory settings. Experimental bentonites showed high adsorption abilities, binding more than 70% of the available AFB1. At the 1:120,000 aflatoxin-to-binder ratio, acid-activated bentonite sequestered over 99% of the AFB1. Human-relevant clinical data are limited but exist: trials using related bentonite-type clays in populations with dietary aflatoxin exposure have reported reductions in aflatoxin biomarkers of approximately 55% in short-term studies, though these results require independent replication and longer-term safety data. Like activated charcoal, bentonite carries the theoretical risk of co-adsorbing essential nutrients.

6.8 Chlorella

Traditional Use

Chlorella is a genus of freshwater green algae that has been consumed as a food source in Japan and other East Asian countries for several decades, gaining widespread use as a nutritional supplement beginning in the mid-20th century.

Scientific Evidence

Researchers examined the ability of Chlorella sorokiniana to detoxify deoxynivalenol (DON), ochratoxin A (OTA), and fumonisin B1 (FB1) in vitro and in vivo. The binding was evaluated in vitro and detoxification was demonstrated by monitoring concentrations in plasma and urine samples of male ICR mice following oral administration. Chlorella sorokiniana bound to more than 80% and 40% of DON and OTA, respectively, whereas binding to FB1 was less than 10%. The concentrations of DON and OTA in plasma and urine samples were substantially reduced by co-administration, whereas Chlorella did not affect FB1 absorption. This is an animal study published in 2025; human data for this application are not yet available. Evidence is therefore very preliminary.

6.9 Yeast Cell Walls (Beta-Glucans and Mannan Oligosaccharides)

Traditional Use

Fermented yeast products have been used in food production and traditional brewing for thousands of years. Their specific use as mycotoxin binders is a modern development with no traditional precedent.

Scientific Evidence

In laboratory studies, many probiotic effects appear to be driven by binding of mycotoxins to bacterial or yeast cell wall components, such as peptidoglycans, teichoic acids, and polysaccharides. These structural components can interact with toxin molecules and reduce their bioavailability in the gut. Yeast cell wall products have shown variable in vitro efficacy depending on pH and the proportional composition of active components; they consistently bind aflatoxins but show inconsistent results with polar mycotoxins such as DON. Human clinical data are lacking.

7. Dietary and Lifestyle Factors

Dietary Patterns and High-Risk Foods

Dietary exposure is the predominant route of mycotoxin intake for most people. Although there is agreement that diet is the main source of mycotoxin exposure, the degree of risk varies substantially by food category. Commodity grains — especially corn, wheat, barley, sorghum, and rice — along with peanuts, tree nuts, spices, dried fruits, coffee, and cocoa are the highest-risk staples globally. The occurrence of mycotoxin contamination is further stimulated by ongoing global warming.

Food Storage and Handling

Appropriate food storage is a primary dietary intervention for reducing mycotoxin exposure. The production of some mycotoxins occurs mainly in the field, while for others it can happen both in the field and in the postharvest period. Maintaining dry storage conditions (low relative humidity), using airtight containers, and discarding visibly molded foods — rather than removing only the visible mold — are recommended practices, as mycotoxins can penetrate soft foods well beyond the visible mold boundary.

Gut Microbiome Support Through Diet

Probiotics and various dietary interventions have been studied for their effects on modulating the effects of toxins including mycotoxins. These treatments have the potential to have significant beneficial effects, as much of the metabolism of toxins occurs via intestinal biotransformation. Ochratoxin A (OTA) undergoes hydroxylation to the less toxic ochratoxin alpha in the intestines, illustrating how gut-level microbial and enzymatic activity can influence mycotoxin toxicity. Dietary strategies supporting a diverse gut microbiota — including adequate dietary fiber, fermented foods, and prebiotic-rich foods — are supported by the broader microbiome literature as potentially relevant to mycotoxin metabolism, though direct human interventional evidence in this context remains limited.

Antioxidant-Rich Dietary Pattern

Oxidative stress plays a significant role in the toxicity of mycotoxins. Dietary patterns rich in diverse antioxidants from whole plant foods — including polyphenols, carotenoids, and vitamins C and E — are biologically plausible as supportive strategies, as these compounds work across multiple antioxidant pathways. However, it should be noted that direct evidence from human trials specifically designed to measure the impact of overall dietary antioxidant intake on mycotoxin-associated outcomes is limited.

Reduction of Total Toxic Load

It is recommended to decrease exposure to other chemical xenobiotic agents including pesticides, heavy metals, volatile organic compounds and fragrances, vinyl chloride, plastics, perfluorinates (nonstick cookware), and other toxins in an effort to reduce total load and improve the ability to detoxify. This "total load" principle is discussed in environmental medicine literature, though rigorous clinical studies quantifying its benefit in mycotoxin contexts are lacking.

Remediation of Indoor Environments

In addition to avoidance of further exposure to water-damaged environments and to items contaminated by these environments, a number of approaches have been used to help persons affected by exposure to restore their health. Source removal — addressing water damage, fixing leaks, and professional remediation of water-damaged materials — is consistently identified in the public health and environmental medicine literature as the foundational intervention, taking priority over any supplementary nutritional or herbal approach.

Food Safety Regulatory Context

The Food and Drug Administration (FDA) has developed strategies and guidelines to minimize mycotoxins in the U.S. food supply. Internationally, regulatory maximum levels for aflatoxins, OTA, fumonisins, deoxynivalenol, and zearalenone in food and feed commodities have been established by the European Commission, WHO, and Codex Alimentarius, reflecting the global public health significance of dietary mycotoxin exposure.

References

• Hardin BD, et al. (2004). Health effects of mycotoxins: a toxicological overview. PubMed.
• Peraica M, et al. (2001). Contamination of food with mycotoxins and human health. PubMed.
• Wild CP & Turner PC. (1999). Toxic effects of mycotoxins in humans. PubMed.
• Obinna N, et al. (2022). Mycotoxins' Toxicological Mechanisms Involving Humans, Livestock and Their Associated Health Concerns: A Review. PMC.
• Hope J. (2013). A Review of the Mechanism of Injury and Treatment Approaches for Illness Resulting from Exposure to Water-Damaged Buildings, Mold, and Mycotoxins. PMC / Scientific World Journal.
• Rzechonek DA, et al. (2023). Endocrine Effect of Some Mycotoxins on Humans: A Clinical Review. PMC.
• Alshammari N. (2023). Mycotoxin source and its exposure causing mycotoxicoses. PMC / Bioinformation.
• Bbosa GS, et al. (2021). Mycotoxins Affecting Animals, Foods, Humans, and Plants: Types, Occurrence, Toxicities, Action Mechanisms, Prevention, and Detoxification Strategies — A Revisit. PMC.
• National Institute of Environmental Health Sciences. Mold. NIEHS.
• Sears ME. (2014). Deficient Glutathione in the Pathophysiology of Mycotoxin-Related Illness. PubMed / Toxins.
• Sears ME. (2014). Deficient Glutathione in the Pathophysiology of Mycotoxin-Related Illness. PMC / Toxins.
• Comprehensive Review of Mycotoxins, Their Toxicity, and Innovative Detoxification Methods. (2025). PMC.
• Clinical Utility of Probiotics Therapy in Managing Mycotoxin Illness. (2023). PMC.
• Comprehensive Review of Dietary Probiotics in Reducing Aflatoxin B1 Toxicity. (2025). MDPI Toxins.
• Comprehensive Review of Dietary Probiotics in Reducing Aflatoxin B1 Toxicity. (2025). PMC.
• The Binding Efficiency and Interaction of Lactobacillus casei Shirota Toward Aflatoxin B1. (2018). PMC / Frontiers in Microbiology.
• An In Vitro Study on the Efficacy of Mycotoxin Sequestering Agents for Aflatoxin B1, Deoxynivalenol, and Zearalenone. (2022). PMC / Toxins.
• Presence of Mycotoxins in Milk Thistle (Silybum marianum) Food Supplements: A Review. (2021). PMC / Toxins.
• Restoring Activity of Milk Thistle (Silybum marianum L.) on Serum Biochemical Parameters, Oxidative Status, Immunity, and Performance in Poultry and Other Animal Species, Poisoned by Mycotoxins: A Review. (2023). PMC / Animals.
• Kang SS, et al. (2010). Comparative effects of curcumin and resveratrol on aflatoxin B1-induced liver injury in rats. PubMed.
• Discovering the Protective Effects of Resveratrol on Aflatoxin B1-Induced Toxicity: A Whole Transcriptomic Study. (2021). PMC.
• Liew WP & Mohd-Redzwan S. (2018). Mycotoxin: Its Impact on Gut Health and Microbiota. PMC / Frontiers in Cellular and Infection Microbiology.
• Mycotoxin-Caused Intestinal Toxicity: Underlying Molecular Mechanisms and Further Directions. (2025). PMC.
• Minich DM & Brown BI. (2019). A Review of Dietary (Phyto)Nutrients for Glutathione Support. PMC / Nutrients.
• Bryła M, et al. (2020). Molecular Aspects of Mycotoxins — A Serious Problem for Human Health. PMC / International Journal of Molecular Sciences.
• Pestka JJ & Bondy GS. (2003). Indoor Mold, Toxigenic Fungi, and Stachybotrys chartarum: Infectious Disease Perspective. PMC / Clinical Microbiology Reviews.
• Effects of Dietary Milk Thistle (Silybum marianum) Supplementation in Ducks Fed Mycotoxin-Contaminated Diets. (2023). PMC / Animals.
• Yamaguchi H, et al. (2025). Oral Exposure to Chlorella sorokiniana Detoxifies Deoxynivalenol, Ochratoxin A, and Fumonisin B1 In Vitro and In Vivo. PMC / Toxins.
• Optimization of modified bentonite mycotoxin binders for enhanced adsorption efficiency. (2025). Scientific Reports.
• University of Nebraska-Lincoln Extension. (2023). Understanding Mycotoxins (EC 3068).